BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2004
View Archived Issues
Efficacy and safety of tacrolimus in fistulizing Crohn's disease
Read More
Combination of CCR5 receptor antagonist and ciclosporin effective against allograft rejection
Read More
Novel inducible nitric oxide synthase inhibitor promising against graft rejection
Read More
Further data on DepoMorphine in postoperative pain control
Read More
Efficacy and pharmacokinetics of Oxytrex in patients with chronic osteoarthritic pain
Read More
Studies show pregabalin to be safe and effective in treating postherpetic neuralgia
Read More
Enrollment under way in phase I study of NQO2 anticancer therapy
Read More
Potent and selective CCR5 antagonists effective against graft rejection in monkey
Read More
Novel CDK2/cyclin A inhibitor effective antitumor agent in vivo
Read More
Novel dual lipid synthesis inhibitor effective for metabolic syndrome and dyslipidemia
Read More
Yamanouchi and Fujisawa sign definitive merger agreement to form Astellas Pharma
Read More
Australian approval for Remodulin in pulmonary arterial hypertension
Read More
Acceptance of Onco TCS NDA triggers payment to Elan
Read More
New European phase III trial for Zadaxin triple therapy in HCV
Read More
Genetronics and Merck in agreement for MedPulser DNA Delivery System
Read More
Approval letter for anidulafungin
Read More
Ketek 99% effective in vitro against S. pneumoniae bacteria
Read More
Sinovac Biotech commences phase I testing of SARS vaccine
Read More
Additional analysis of response data from phase III Dacogen study in MDS
Read More
Nadixa launched in Germany
Read More
AstraZeneca confirms safety of Crestor
Read More
Plenaxis commercialization and development progress
Read More
Initial NICE recommendations for Glivec rebutted by Novartis
Read More
Rigel initiates phase I/II trial for R-803 in HCV
Read More
Oxigene updates Q1 development progress
Read More
Novel beta2-adrenoceptor agonist effective against bronchoconstriction in vivo
Read More
New PARP inhibitors for acute brain infarction developed at Mitsubishi Pharma
Read More
Ono scientists identify novel edg2 receptor antagonists
Read More
Dual dopamine D2/5-HT1A agonists with potential as antiparkinsonian agents
Read More
New GABA-A receptor modulators in early development at Neurogen
Read More
Ono claims new prostaglandin derivatives for use in bone disorders
Read More
Ube scientists prepare and test novel p38 MAP kinase inhibitors
Read More